Pacira BioSciences (STU:82P) Total Liabilities : €635.9 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Pacira BioSciences Total Liabilities?

Pacira BioSciences's Total Liabilities for the quarter that ended in Mar. 2024 was €635.9 Mil.

Pacira BioSciences's quarterly Total Liabilities declined from Sep. 2023 (€658.63 Mil) to Dec. 2023 (€645.80 Mil) and declined from Dec. 2023 (€645.80 Mil) to Mar. 2024 (€635.87 Mil).

Pacira BioSciences's annual Total Liabilities declined from Dec. 2021 (€1,190.28 Mil) to Dec. 2022 (€855.44 Mil) and declined from Dec. 2022 (€855.44 Mil) to Dec. 2023 (€645.80 Mil).

Pacira BioSciences Total Liabilities Historical Data

The historical data trend for Pacira BioSciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacira BioSciences Total Liabilities Chart

Pacira BioSciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

428.51

538.27

1,190.28

855.44

645.80

Pacira BioSciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															705.52	677.86	658.63	645.80	635.87

Pacira BioSciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Pacira BioSciences's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	89.3	+	(521.408	+	35.095
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	645.8

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	1443.712	-	797.909
	=	645.8

Pacira BioSciences's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	85.968	+	(519.002	+	30.896
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	635.9

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	1456.655	-	820.789
	=	635.9

Pacira BioSciences Total Liabilities Related Terms

Thank you for viewing the detailed overview of Pacira BioSciences's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Pacira BioSciences (STU:82P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pacira BioSciences Inc (STU:82P) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

PCRX:USA 82P:Germany

Address

5401 West Kennedy Boulevard, Suite 890, Tampa, FL, USA, 33609

Website

https://www.pacira.com

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has launched EXPAREL which utilizes DepoFoam, a product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time.

Pacira BioSciences (STU:82P) Headlines

No Headlines